Resmed Inc (RMD) Stock Price, Quote & News

Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry,...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 858-836-5000

Website: www.resmed.com

Address:

9001 Spectrum Center Boulevard, San Diego, United States

BillionerOfKing Feb. 2 at 5:19 PM

$RMD Current Stock Price: $251.96 Contracts to trade: $250.0 RMD Feb 20 2026 Call Entry: $6.40 Exit: $11.60 ROI: 81% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

erevnon Jan. 30 at 3:16 PM

Stifel maintains ResMed $RMD at Hold and raises the price target from $260 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

InLongtoRetire Jan. 30 at 1:47 PM

$RMD

0 · Reply

stockro1 Jan. 30 at 6:52 AM

$IXHL I listened to the $RMD earbings call last night and it just continued to reinforced the amazing potential Incannex has for OSA. As much as it is impressive building hardware to fix the issue, medication is undoubtedly the way forward for the masses. The convenience and the barrier to entry is so much more favourable for Incannex vs needing to wear a headset whilst sleeping. There could be a future where both exist i.e. thoughts maybe Resmed for for serious conditions and Incannex more general population. However, the unequivocal fact is that, if done right and given the growing insight and science into the consequences of OSA, Incannex could have a really a once in a generation drug in its portfolio with IHL-42X that any big pharmaceutical company would want to have. And that’s without even mentioning PSX-001.

0 · Reply

howardlindzon Jan. 30 at 5:11 AM

$RMD sleep perking...

0 · Reply

LazySoo Jan. 29 at 10:38 PM

$IXHL $RMD don’t forget to equip your PPE before bedtime!

0 · Reply

1986iamwallstreet Jan. 29 at 10:38 PM

$RMD hey won’t quantify the GLP-1 tailwind (yet) Multiple questions on GLP-1 impact and they refused to size it (“not prepared to publicly talk about it yet”). Translation: if you’re trying to model “how much of devices growth is GLP-1 vs normal vs share gain,” they’re not giving you the bridge. 🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸

0 · Reply

1986iamwallstreet Jan. 29 at 10:37 PM

$RMD Senior living / long-term care vertical is still a problem CFO explicitly said Fox (Germany) is strong, but senior living / long-term care is “ongoing challenges” and is offsetting. Translation: the weakness is structural enough that it’s still being called out. 🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸

0 · Reply

1986iamwallstreet Jan. 29 at 10:36 PM

$RMD RCS software is still not “fixed” (and they’re basically admitting FY26 is a bridge year) They said Residential Care Software (RCS) is in portfolio management mode and they expect mid-single digit growth in March + June quarters while they “work through” it. They’re pushing the real “back to sustainable high-single digit growth + double-digit op profit growth” to FY2027. Translation: software drag persists, and FY26 isn’t the clean re-acceleration year for that segment. 🩸🩸🩸🩸🩸🩸🩸🩸🩸🩸

0 · Reply

J4y000 Jan. 29 at 10:33 PM

$IXHL I’d rather ride with IXHL into the pits of hell than invest in $RMD

0 · Reply

Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge

NVO

Feb 1, 2026, 12:54 AM EST - 2 days ago

ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell

Jan 30, 2026, 1:08 PM EST - 4 days ago

Analysts Maintain Bull Case On ResMed Despite Competition Concerns

Jan 29, 2026, 8:23 PM EST - 5 days ago

ResMed Inc. (RMD) Q2 2026 Earnings Call Transcript

Jan 29, 2026, 4:41 PM EST - 5 days ago

ResMed beats quarterly profit estimates on strong demand for its sleep devices

Jan 29, 2026, 4:05 PM EST - 5 days ago

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026

Jan 12, 2026, 6:56 PM EST - 22 days ago

ResMed Inc. (RMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 8, 2026, 4:05 PM EST - 26 days ago

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

Dec 18, 2025, 4:05 PM EST - 6 weeks ago

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Dec 8, 2025, 9:03 PM EST - 2 months ago

Top 50 High-Quality Dividend Growth Stocks For December 2025

ACN ALLE APH DHI DPZ FDS GGG

Dec 8, 2025, 9:00 AM EST - 2 months ago

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

Nov 24, 2025, 2:15 PM EST - 2 months ago

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

IDXX

Nov 17, 2025, 5:24 PM EST - 2 months ago

ResMed: Safe Bet For A Recession Environment

Oct 31, 2025, 9:24 AM EDT - 3 months ago

These Analysts Revise Their Forecasts On ResMed Following Q1 Results

Oct 30, 2025, 10:16 PM EDT - 3 months ago

ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript

Oct 30, 2025, 4:05 PM EDT - 3 months ago

Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026

Oct 9, 2025, 4:05 PM EDT - 4 months ago

Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025

Oct 3, 2025, 10:46 AM EDT - 4 months ago

Top 50 High-Quality Dividend Growth Stocks For October 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Sep 23, 2025, 11:53 AM EDT - 4 months ago

ResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Sep 16, 2025, 4:05 PM EDT - 5 months ago

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

Sep 8, 2025, 9:00 PM EDT - 5 months ago

The sleep economy is 'having a moment', says medical equipment firm Resmed

Sep 6, 2025, 12:18 PM EDT - 5 months ago

Top 50 High-Quality Dividend Stocks For September 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Sep 3, 2025, 4:15 PM EDT - 5 months ago

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

Aug 27, 2025, 9:00 AM EDT - 5 months ago

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

Aug 27, 2025, 7:43 AM EDT - 5 months ago

ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows

Aug 18, 2025, 4:15 PM EDT - 6 months ago

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Aug 6, 2025, 11:50 AM EDT - 6 months ago

Top 50 High-Quality Dividend Stocks For August 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Aug 1, 2025, 2:16 PM EDT - 6 months ago

ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings

Jul 31, 2025, 9:39 PM EDT - 6 months ago

ResMed Inc. (RMD) Q4 2025 Earnings Call Transcript

Jul 31, 2025, 4:53 PM EDT - 6 months ago

Resmed beats quarterly profit estimates on strong demand for sleep devices

Jul 31, 2025, 4:05 PM EDT - 6 months ago

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025

Jul 30, 2025, 6:08 AM EDT - 6 months ago

Spot Outliers Like ResMed Early with Money Flows

Jul 1, 2025, 9:02 PM EDT - 7 months ago

Top 15 High-Growth Dividend Stocks For July 2025

APH BAC BK DKS DPZ ELV GPN

Jul 1, 2025, 4:05 PM EDT - 7 months ago

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025

Jun 9, 2025, 5:38 AM EDT - 8 months ago

ResMed: A Sleeping Giant Hiding In Plain Sight

Jun 2, 2025, 10:00 AM EDT - 8 months ago

Top 15 High-Growth Dividend Stocks For June 2025

DKS DPZ GPN INTU KLAC LRCX MPWR

May 15, 2025, 9:00 AM EDT - 9 months ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

May 2, 2025, 11:21 AM EDT - 9 months ago

Top 15 High-Growth Dividend Stocks To Consider For May 2025

AMAT APH DKS DPZ GPN INTU LRCX

May 1, 2025, 9:00 AM EDT - 9 months ago

Resmed Acquires VirtuOx

Apr 24, 2025, 3:24 PM EDT - 10 months ago

ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast

Apr 24, 2025, 5:12 AM EDT - 10 months ago

ResMed: Cornering The Market In Sleep Solutions

Apr 23, 2025, 7:16 PM EDT - 10 months ago

ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript

Apr 23, 2025, 5:08 PM EDT - 10 months ago

ResMed slightly beats quarterly profit estimates on sleep devices demand

Apr 23, 2025, 4:05 PM EDT - 10 months ago

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Apr 21, 2025, 5:00 PM EDT - 10 months ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Apr 3, 2025, 9:00 AM EDT - 10 months ago

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

Apr 2, 2025, 4:05 PM EDT - 10 months ago

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Apr 2, 2025, 2:12 AM EDT - 10 months ago

My Top 15 High-Growth Dividend Stocks For April 2025

AMAT APH DPZ GPN INTU LRCX MPWR

Mar 19, 2025, 8:00 AM EDT - 11 months ago

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

Mar 11, 2025, 9:00 AM EDT - 11 months ago

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

BillionerOfKing Feb. 2 at 5:19 PM

0 · Reply

erevnon Jan. 30 at 3:16 PM

Stifel maintains ResMed $RMD at Hold and raises the price target from $260 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

InLongtoRetire Jan. 30 at 1:47 PM

$RMD

0 · Reply

stockro1 Jan. 30 at 6:52 AM

0 · Reply

howardlindzon Jan. 30 at 5:11 AM

$RMD sleep perking...

0 · Reply

LazySoo Jan. 29 at 10:38 PM

$IXHL $RMD don’t forget to equip your PPE before bedtime!

0 · Reply

1986iamwallstreet Jan. 29 at 10:38 PM

0 · Reply

1986iamwallstreet Jan. 29 at 10:37 PM

0 · Reply

1986iamwallstreet Jan. 29 at 10:36 PM

0 · Reply

J4y000 Jan. 29 at 10:33 PM

$IXHL I’d rather ride with IXHL into the pits of hell than invest in $RMD

0 · Reply

macdub8 Jan. 29 at 10:02 PM

$IXHL Again, $RMD made reference to finalizing "tuck-in acquisitions". Hmmm

1 · Reply

StocktwitsEarnings Jan. 29 at 9:14 PM

$RMD Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $2.69 up 14.47% YoY • Reported revenue of $1.42B up 10.98% YoY

0 · Reply

RyanWxm1 Jan. 29 at 7:02 PM

$IXHL $RMD 🧐

0 · Reply

Estimize Jan. 29 at 4:00 PM

$RMD reports after the close, Estimize Consensus -0.01 EPS and +3.10M Revs compared to WS http://www.estimize.com/rmd/fq2-2026?utm_content=

0 · Reply

1986iamwallstreet Jan. 29 at 2:52 PM

$RMD flush city in play 🩸🩸🩸🩸👀

0 · Reply

_Rocket Jan. 29 at 7:16 AM

$IXHL $RMD please just buy IHL-42X today so we can all finally make some money on this.

0 · Reply

macdub8 Jan. 28 at 10:14 PM

$IXHL $RMD

1 · Reply

macdub8 Jan. 28 at 10:12 PM

$IXHL Listen its unlikely that $RMD buy us out..but this soundbite from their October 2025 earnings reports has always got me. I noted it at that time. IXHL would be precisely a "tuck-in acquisition" on the definition of it.

0 · Reply

ZacksResearch Jan. 27 at 1:05 PM

$RMD set to report Q2 fiscal 2026 earnings — will the streak continue? 📈 Resmed has beaten estimates in four consecutive quarters, with a 3.04% average surprise. For Q2, the Zacks Consensus Estimate suggests a 10.3% EPS rise to $2.68. Full preview here 👉 https://www.zacks.com/stock/news/2823147/resmeds-q2-earnings-on-deck-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2823147-body-30380&ADID=SYND_STOCKTWITS_TWEET_2_2823147_BODY_30380

0 · Reply

ZacksResearch Jan. 27 at 12:05 PM

$RMD earnings coming up — are growth tailwinds lining up? 👀 Q2 results are set for Jan. 29, with revenues likely to jump 8.3% and EPS 10.3%, driven by strength across masks, devices, and software. Will this momentum show up in the numbers? Full earnings setup here 👉 https://www.zacks.com/stock/news/2823147/resmeds-q2-earnings-on-deck-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2823147-teaser-30371&ADID=SYND_STOCKTWITS_TWEET_2_2823147_TEASER_30371

0 · Reply

SuperGreenToday Jan. 14 at 8:29 PM

$RMD Share Price: $259.43 Contract Selected: Jul 17, 2026 $260 Calls Buy Zone: $17.43 – $21.53 Target Zone: $30.17 – $36.87 Potential Upside: 63% ROI Time to Expiration: 183 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Bigsky007 Jan. 13 at 8:56 PM

$EVTV $IXHL $JAZZ $LLY $RMD Well BB 23 you picked a good day for a recap. I needed a refresher course.

1 · Reply

Market Cap	37.70B
Revenue (ttm)	5.15B
Net Income (ttm)	1.40B
EPS (ttm)	N/A
PE Ratio	25.06
Forward PE	23.71
Profit Margin	27.22%
Debt to Equity Ratio	0.07

Volume	1,285,500
Avg Vol	972,640
Day's Range	N/A - N/A
Shares Out	145.94M
Stochastic %K	33%
Beta	0.88
Analysts	Sell
Price Target	$292.08